Kestine

Medicinal product

(Invented) name

Kestine

Active substance (s)

Ebastinas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX22, Ebastine

Marketing authorisation holder

Almirall, S.A., Ispanija

Date of authorisation

2003-11-11

Date of renewal

2011-01-17

Documents

2295 Kestine 20mg II PL 2021 09 20.docx

2295 Pakuotės lapelis 20mg 2021 09 20.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ebastinas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6614	11680	1011680	lizdinė plokštelė	N10		Receptinis	LT/1/98/2295/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2011-01-17	Perregistruotas
2003-11-11	Registruotas